Exelixis
EXEL
#1641
Rank
S$14.10 B
Marketcap
$49.39
Share price
0.64%
Change (1 day)
62.74%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company